AXSM
Axsome Therapeutics·NASDAQ
--
--(--)
--
--(--)
AXSM fundamentals
Axsome Therapeutics (AXSM) expects to report earnings on Feb 23, 2026, with estimated revenue of 192.92M (YoY +62.44%), and EPS at -0.6941 (YoY +54.93%).
Revenue estimate / YoY
192.92M
+62.44%
EPS estimate / YoY
-0.6941
+54.93%
Report date
Feb 23, 2026
EPS
Revenue
Revenue & Expenses
AXSM has released its 2025 Q3 earnings report, with revenue of 170.99M, reflecting a YoY change of 63.22%, and net profit of -47.23M, showing a YoY change of 26.89%. The Sankey diagram below clearly presents AXSM's revenue sources and cost distribution.
Key Indicators
Axsome Therapeutics (AXSM) key financial stats and ratios, covering profitability, financial health, and leverage.
Axsome Therapeutics (AXSM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Axsome Therapeutics (AXSM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Axsome Therapeutics (AXSM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Axsome Therapeutics (AXSM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Axsome Therapeutics (AXSM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Axsome Therapeutics next quarter?What were the key takeaways from Axsome Therapeutics’s earnings call?What is Axsome Therapeutics's gross profit margin?What factors drove the changes in Axsome Therapeutics's revenue and profit?What guidance did Axsome Therapeutics's management provide for the next earnings period?What does Axsome Therapeutics do and what are its main business segments?What were the key takeaways from Axsome Therapeutics's earnings call?What is the revenue and EPS growth rate for Axsome Therapeutics year over year?
